IRIS Accounts Production v24.3.2.46 08737113 Board of Directors 1.1.24 31.12.24 31.12.24 0 0 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh087371132023-12-31087371132024-12-31087371132024-01-012024-12-31087371132022-12-31087371132023-01-012023-12-31087371132023-12-3108737113ns15:EnglandWales2024-01-012024-12-3108737113ns14:PoundSterling2024-01-012024-12-3108737113ns10:Director12024-01-012024-12-3108737113ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3108737113ns10:SmallEntities2024-01-012024-12-3108737113ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3108737113ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3108737113ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3108737113ns10:FullAccounts2024-01-012024-12-3108737113ns10:OrdinaryShareClass12024-01-012024-12-3108737113ns5:CurrentFinancialInstruments2024-12-3108737113ns5:CurrentFinancialInstruments2023-12-3108737113ns5:ShareCapital2024-12-3108737113ns5:ShareCapital2023-12-3108737113ns5:RetainedEarningsAccumulatedLosses2024-12-3108737113ns5:RetainedEarningsAccumulatedLosses2023-12-3108737113ns10:RegisteredOffice2024-01-012024-12-3108737113ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3108737113ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3108737113ns10:OrdinaryShareClass12024-12-31
REGISTERED NUMBER: 08737113 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Neurolixis UK Limited

Neurolixis UK Limited (Registered number: 08737113)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


Neurolixis UK Limited (Registered number: 08737113)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £   
CURRENT ASSETS
Debtors 4 1,325 1,014
Cash at bank 2,136 2,775
3,461 3,789
CREDITORS
Amounts falling due within one year 5 36,177 32,880
NET CURRENT LIABILITIES (32,716 ) (29,091 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(32,716

)

(29,091

)

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings (32,816 ) (29,191 )
SHAREHOLDERS' FUNDS (32,716 ) (29,091 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Neurolixis UK Limited (Registered number: 08737113)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 March 2025 and were signed on its behalf by:





A Newman-Tancredi - Director


Neurolixis UK Limited (Registered number: 08737113)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Neurolixis UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08737113

Registered office: 27 Old Gloucester Street
London
United Kingdom
WC1N 3AX

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial instruments
All of the financial instruments of the company are basic and the company has elected to apply the provisions of Section 11 "Basic Financial Instruments of FRS 102 to all its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Cash and cash equivalents
Cash is represented by cash and deposits with financial institutions repayable without penalty on notice of not more than 24 hours.

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Neurolixis UK Limited (Registered number: 08737113)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued

Going concern
The directors have a reasonable expectation that the company will continue to have adequate resources to remain in operational existence for the foreseeable future and also for a period of more than one year from the date of approval of these accounts. In addition to this, continued support will be available from the shareholders for the foreseeable future. Therefore, the going concern assumption has been applied in preparing these financial statements.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Other debtors 1,325 1,014

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 1 1
Amounts owed to group undertakings 33,735 31,235
Other creditors 2,441 1,644
36,177 32,880

6. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
100 Share capital 1 1 100 100

7. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Neurolixis Inc, a company incorporated in USA.